{"filing":{"accession_number":"0001062993-26-003717","cik":"0001769697","ticker":"FNUC","company_name":"Frontier Nuclear \u0026 Minerals Inc.","form":"6-K","filing_date":"2026-07-20","report_date":null,"primary_document":"form6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1769697/000106299326003717/form6k.htm"},"events":[{"id":18723,"run_id":16842,"accession_number":"0001062993-26-003717","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states \"The Board has appointed Joshua Girnun...and Donal Carroll...as new directors\" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.","company_name":"Frontier Nuclear \u0026 Minerals Inc.","ticker":"FNUC","filing_date":"2026-07-20","form":"6-K","submitted_at":null,"items":[{"id":17622,"accession_number":"0001062993-26-003717","item_number":"EX-99.1","item_title":"exhibit99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states \"The Board has appointed Joshua Girnun...and Donal Carroll...as new directors\" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-20T14:06:45.177963+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17622,"accession_number":"0001062993-26-003717","item_number":"EX-99.1","item_title":"exhibit99-1.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states \"The Board has appointed Joshua Girnun...and Donal Carroll...as new directors\" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-20T14:06:45.177963+00:00","company_name":"Frontier Nuclear \u0026 Minerals Inc.","ticker":"FNUC","filing_date":"2026-07-20"}]}